Mariam S. DEGANI - Search Results

Year	Number of Results
2008	1
2009	1
2010	8
2011	6
2013	4
2014	2
2015	6
2016	4
2017	1
2018	1
2019	2
2020	2
2021	2
2022	1
2023	4
2024	0

1

Oxadiazole scaffolds in anti-tuberculosis drug discovery.

De SS, Khambete MP, Degani MS. De SS, et al. Among authors: degani ms. Bioorg Med Chem Lett. 2019 Aug 15;29(16):1999-2007. doi: 10.1016/j.bmcl.2019.06.054. Epub 2019 Jun 28. Bioorg Med Chem Lett. 2019. PMID: 31296357 Review.

2

Repositioning of DHFR Inhibitors.

Lele AC, Mishra DA, Kamil TK, Bhakta S, Degani MS. Lele AC, et al. Curr Top Med Chem. 2016;16(19):2125-43. doi: 10.2174/1568026616666160216152540. Curr Top Med Chem. 2016. PMID: 26881719 Review.

3

Tackling SARS-CoV-2: proposed targets and repurposed drugs.

Joshi S, Joshi M, Degani MS. Joshi S, et al. Among authors: degani ms. Future Med Chem. 2020 Sep;12(17):1579-1601. doi: 10.4155/fmc-2020-0147. Epub 2020 Jun 22. Future Med Chem. 2020. PMID: 32564623 Free PMC article. Review.

4

Antimicrobial potential of quaternary phosphonium salt compounds: a review.

Ibrahim MK, Haria A, Mehta NV, Degani MS. Ibrahim MK, et al. Among authors: degani ms. Future Med Chem. 2023 Nov;15(22):2113-2141. doi: 10.4155/fmc-2023-0188. Epub 2023 Nov 6. Future Med Chem. 2023. PMID: 37929337 Review.

5

The expanding repertoire of covalent warheads for drug discovery.

Mehta NV, Degani MS. Mehta NV, et al. Among authors: degani ms. Drug Discov Today. 2023 Dec;28(12):103799. doi: 10.1016/j.drudis.2023.103799. Epub 2023 Oct 13. Drug Discov Today. 2023. PMID: 37839776 Review.

6

Antituberculosis activity of polyphenols of Areca catechu.

Raju A, De SS, Ray MK, Degani MS. Raju A, et al. Int J Mycobacteriol. 2021 Jan-Mar;10(1):13-18. doi: 10.4103/ijmy.ijmy_199_20. Int J Mycobacteriol. 2021. PMID: 33707366

7

Elemental exchange: Bioisosteric replacement of phosphorus by boron in drug design.

Mehta NV, Abhyankar A, Degani MS. Mehta NV, et al. Among authors: degani ms. Eur J Med Chem. 2023 Nov 15;260:115761. doi: 10.1016/j.ejmech.2023.115761. Epub 2023 Aug 25. Eur J Med Chem. 2023. PMID: 37651875 Review.

8

Rational design of coumarin derivatives as antituberculosis agents.

Mali HM, Sabale SS, Degani MS, Borkute R, Choudhari AS, Sarkar D, Krishna VS, Sriram D. Mali HM, et al. Among authors: degani ms. Future Med Chem. 2018 Oct;10(20):2431-2444. doi: 10.4155/fmc-2018-0015. Epub 2018 Oct 16. Future Med Chem. 2018. PMID: 30325198

9

A review of molecular modelling studies of dihydrofolate reductase inhibitors against opportunistic microorganisms and comprehensive evaluation of new models.

Tawari NR, Bag S, Degani MS. Tawari NR, et al. Among authors: degani ms. Curr Pharm Des. 2011;17(7):712-51. doi: 10.2174/138161211795428966. Curr Pharm Des. 2011. PMID: 21395543 Review.

10

Exploring the potential of pyrazoline containing molecules as Aβ aggregation inhibitors in Alzheimer's disease.

Khambete MP, Khare LP, Kapadia AB, Degani MS. Khambete MP, et al. Drug Metab Pers Ther. 2020 Aug 10;35(3). doi: 10.1515/dmpt-2019-0031. Drug Metab Pers Ther. 2020. PMID: 32776895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

38 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year